---
figid: PMC3236828__10555_2011_9317_Fig1_HTML
figtitle: Canonical signaling pathways activated by the EP receptors for PGE2
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
- Moolgarda engeli
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Arabidopsis thaliana
pmcid: PMC3236828
filename: 10555_2011_9317_Fig1_HTML.jpg
figlink: /pmc/articles/PMC3236828/figure/Fig1/
number: F1
caption: Canonical signaling pathways activated by the EP receptors for PGE2. EP1
  activates phospholipase C (PLC), resulting in the production of 1,2-diacylglycerol
  (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG activates protein kinase C (PKC)
  while IP3 mobilizes Ca2+. EP2 activates adenylate cyclase (AC) which results in
  elevated cAMP synthesis and protein kinase A (PKA) activation. EP3 negatively regulates
  AC and thus cAMP levels are reduced. EP4 activates both the AC/cAMP pathway and
  the PI3K/AKT pathway. The activation of these signaling pathways by the EP receptors
  in skin results in biological changes that are associated with the promotion and
  progression of NMSC
papertitle: The role of the EP receptors for prostaglandin E2 in skin and skin cancer.
reftext: J. E. Rundhaug, et al. Cancer Metastasis Rev. 2011 Dec;30(3-4):465-480.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9650862
figid_alias: PMC3236828__F1
figtype: Figure
redirect_from: /figures/PMC3236828__F1
ndex: 437a0140-deb4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3236828__10555_2011_9317_Fig1_HTML.html
  '@type': Dataset
  description: Canonical signaling pathways activated by the EP receptors for PGE2.
    EP1 activates phospholipase C (PLC), resulting in the production of 1,2-diacylglycerol
    (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG activates protein kinase C (PKC)
    while IP3 mobilizes Ca2+. EP2 activates adenylate cyclase (AC) which results in
    elevated cAMP synthesis and protein kinase A (PKA) activation. EP3 negatively
    regulates AC and thus cAMP levels are reduced. EP4 activates both the AC/cAMP
    pathway and the PI3K/AKT pathway. The activation of these signaling pathways by
    the EP receptors in skin results in biological changes that are associated with
    the promotion and progression of NMSC
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX1
  - PTGS1
  - PTGS2
  - PTGER1
  - PTGER2
  - SPAG11B
  - PTGER3
  - PTGER4
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - Ptgs1
  - Ptgs2
  - Ptger1
  - Lypd8l
  - Ptger2
  - Ptger3
  - Ptger4
  - Hspg2
  - ac
  - Pik3r1
  - Akt1
  - Ubap2l
  - Pik3cg
  - Prkcg
  - COX2
  - norpA
  - sl
  - Plc21C
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - cox1
  - cox2
  - EP1
  - EP3
  - VPS34
  - PGE2
  - Cancer
---
